1Bissallah A Ekele,Danjuma Muhammed,Lawal N Bello,et al.Magnesium sulphate therapy in eclampsia:the Sokoto (ultra short) regimen[J].BMC Res Notes,2009,19(2):165.
2Simon P,Fauchet R,Ang KS,et al.Association of HLA DR4 with the risk of recurrence of pregnancy hypertension[J].Kidney Int Suppl,1988,25:125-128.
3Saba R,Goodman CD,Huzarewich RL.A miRNA Signature of Prion Induced Neurodegeneration[J].Plo S ONE,2008,3(11):1-11.
4He G,Liu X,Fan P,et al.The C825T polymorphism in the G-protein beta 3 subunit gene in Chinese patients with preeclampsia[J].Hypertens Pregnancy,2009,28(2):156-167.
5De Lima TH,Sass N,Mattar R.Cytokine gene polymorphisms in preeclampsia and eclampsia[J].Hypertens Res,2009,32(7):565-569.
6Akbar SA,Khawaja NP,Brown PR,et al.Angiotensin II type 1 and 2 receptors gene polymorphisms in pre-eclampsia and normal pregnancy in three different populations[J].Acta Obstet Gynecol Scand,2009,88(5):606-611.
7Pineles BL,Romero R,Montenegro D.Distinct subsets of microRNAs are expressed differentially in the human placentas of patients with preeclampsia[J].Am J Obstet Gynecol,2007,196(3):261-266.
8Celik N,Ozan H.Maternal serum mannose-binding lectin in severe preeclampsia[J].Clin Exp Obstet Gynecol,2008,35(3):179-182.
9Van de Geijn FE,Dolhain RJ,Van Rijs W,et al.Mannose-binding lectin genotypes and pre-eclampsia:a case-control study[J].Hum Immunol,2007,68(11):888-893.
2Miller SL,Chai M,Loose J,et al.The effects of maternal betamethasone administration on the intrauterine growthrestricted fetus[J].Endocrinology,2007,148(3):1288.
3Nozaki AM,Francisco RP,Fonseca ES,et al.Fetal hemodynamic changes following maternal betamethasone administration in pregnancies with fetal growth restriction and absent end-diastolic flow in the umbilical artery[J].Acta Obstet Gynecol Scand,2009,26(1):1.
4Steinberg G,Khankin EV,Karumanchi SA.Angiogenic factors and preeclampsia.Thromb Res,2009,123(Suppl 2):S93-S99.
5Polliotti BM,Fry AG,Saller DN,et al.Second-trimester maternal serum placental growth factor and vascular endothelial growth factor for predicting severe,early-onset preeclampsia.Obstet Gynecol,2003,101:1266-1274.
6Mohaupt M.Molecular aspects of preeclampsia.Mol Aspects Med,2007,28:169-191.
7Naicker T,Khedun SM,Moodley J,et al.Quantitative analysis of trophoblast invasion in preeclampsia.Acta Obstet Gynecol Scand,2003,82:722-729.
9Bridges JP,Gilbert JS,Colson D,et al.Oxidative stress contributes to soluble fms-like tyrosine kinase-1 induced vascular dysfunction in pregnant rats.Am J Hypertens,2009,22:564-568.
10Gu Y,Lewis DF,Wang Y.Placental productions and expressions of soluble endoglin,soluble fms-like tyrosine kinase receptor-1,and placental growth factor in normal and preeclamptic pregnancies.J Clin Endocrinol Metab,2008,93:260-266.
